{
    "2020-12-29": [
        [
            {
                "time": "",
                "original_text": "医药行业一周观察：持续推荐三大主线 紧握高性价比的核心资产",
                "features": {
                    "keywords": [
                        "医药行业",
                        "三大主线",
                        "核心资产",
                        "高性价比"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：海外疫情引关注 “国谈”下创新药企业面临新考验",
                "features": {
                    "keywords": [
                        "医药行业",
                        "海外疫情",
                        "国谈",
                        "创新药企业",
                        "新考验"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "35股获券商买入评级 华宇软件目标涨幅达93.41%",
                "features": {
                    "keywords": [
                        "券商买入评级",
                        "华宇软件",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "信息技术"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【山证医药】医药行业周报（20201228）：新冠疫苗上市临近，持续关注后续动态",
                "features": {
                    "keywords": [
                        "医药行业",
                        "新冠疫苗",
                        "上市临近",
                        "后续动态"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：已彻底走出“疫苗门”阴霾？",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "疫苗门",
                        "阴霾"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}